This week on The Beat, CTSNet Editor-in-Chief Joel Dunning had the opportunity to speak with Dr. Hazem Fallouh about his latest invention for diagnosing cardiac tamponade at the 2024 Birmingham Review Course. They discussed the purpose of this invention, how it went from an idea to being created, and how Dr. Hazem will get this product on the market.  

Joel also reviews recent JANS articles on initial experience with transcatheter aortic valve replacement before and after lung transplant, a report of salaries of academic cardiothoracic surgeons based on race and ethnicity, chest wall resection and reconstruction for primary chest wall sarcomas, and seven-year outcomes following aortic valve replacement with a novel tissue bioprosthesis.  

In addition, Joel explores an introduction to redo sternotomy, emergency VATS esophagectomy for T4 esophageal cancer with massive hematemesis in an elderly patient, and pectus excavatum with hemodynamic repercussion corrected by the cross-bar technique with cryoanalgesia. Before closing, he shares upcoming events in CT surgery. 

JANS Items Mentioned

1.) Initial Experience With Transcatheter Aortic Valve Replacement Before and After Lung Transplant 

2.) A Report of Salaries of Academic Cardiothoracic Surgeons Based on Race and Ethnicity 

3.) Chest Wall Resection and Reconstruction for Primary Chest Wall Sarcomas: Analysis of Survival, Predictors of Outcome, and Long-Term Functional Status 

4.) Seven-Year Outcomes Following Aortic Valve Replacement With a Novel Tissue Bioprosthesis. THE COMMENCE Trial - Looking at RESILIA  

CTSNet Content Mentioned 

1.) An Introduction to Redo Sternotomy  

2.) Emergency VATS Esophagectomy for T4 Esophageal Cancer With Massive Hematemesis in an Elderly Patient 

3.) Pectus Excavatum With Hemodynamic Repercussion Corrected by the Cross-Bar Technique With Cryoanalgesia 

Other Items Mentioned 

CTSNet Events Calendar 

Disclaimer

The information and views presented on CTSNet.org represent the views of the authors and contributors of the material and not of CTSNet. Please review our full disclaimer page here.